Biohaven Ltd. - BHVN

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q2 2026 · Q1 2026
Value (USD)
Total reported value ($000)
$2.295B
QoQ value delta ($000)
+$1.067B (+86.89%)
Implied price effect (QoQ)
+67.05%
Shares
Total shares
162,377,236
QoQ shares delta
+17,244,397 (+11.88%)
Total shares held by funds (by quarter)

Market chart (BHVN)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q2 2026)

Top 25 only Full list
Partial Q2 2026 data: 297 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
BlackRock, Inc. 196,573 13,210,585 0.0%
MONTANOVA CAPITAL, LLC 153,069 10,286,937 2.8%
JANUS HENDERSON GROUP PLC 148,213 17,534,612 0.07%
STIFEL FINANCIAL CORP 147,924 9,941,165 0.12%
Jupiter Topco LLC 127,851 8,584,675 0.05%
Woodline Partners LP 113,984 7,660,280 0.35%
STATE STREET CORP 103,371 6,947,034 0.0%
INFINITUM ASSET MANAGEMENT, LLC 93,000 6,250,000 9.46%
D. E. Shaw & Co., Inc. 62,350 4,190,195 0.03%
AQR CAPITAL MANAGEMENT LLC 61,761 4,150,616 0.02%
GEODE CAPITAL MANAGEMENT, LLC 49,460 3,323,190 0.0%
FMR LLC 44,113 2,964,630 0.0%
Royalty Pharma Sub-Manager, LLC 43,695 2,936,507 18.06%
Cormorant Asset Management, LP 38,836 2,610,000 1.99%
GOLDMAN SACHS GROUP INC 38,435 2,583,046 0.0%
UBS Group AG 37,480 2,518,827 0.0%
VANGUARD PORTFOLIO MANAGEMENT LLC 37,035 2,488,941 0.0%
CITADEL ADVISORS LLC 30,405 2,043,376 0.0%
BALYASNY ASSET MANAGEMENT L.P. 27,970 1,879,734 0.03%
TCG Crossover Management, LLC 26,485 1,779,952 0.64%
Nuveen, LLC 25,955 1,744,334 0.01%
Rubric Capital Management LP 25,615 1,721,493 0.23%
VANGUARD CAPITAL MANAGEMENT LLC 22,153 1,488,809 0.0%
BANK OF AMERICA CORP /DE/ 21,990 1,477,838 0.0%
PRICE T ROWE ASSOCIATES INC /MD/ 21,679 1,456,851 0.0%